Skip to content
MarketScale
‹ Back to IndustriesHealthcare

Healthcare Cyberattacks Grew in 2022. How Should the Industry Combat Them?

Concerning data from cybersecurity firm Check Point indicates an increase in cyberattacks on healthcare organizations by 74% in 2022 from the previous year. Healthcare is currently the third most attacked global industry (1,463 attacks per week) behind government/military (1,661 attacks per week) and education/research (2,314 attacks per week.) And in the United States, Healthcare ranks…

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

Share

Get featured

Want to get featured in MarketScale Healthcare?

Create a free MarketScale workspace and get your company's expertise featured across our Healthcare coverage. No credit card, no demo required.

Request an invite

Concerning data from cybersecurity firm Check Point indicates an increase in cyberattacks on healthcare organizations by 74% in 2022 from the previous year.

Healthcare is currently the third most attacked global industry (1,463 attacks per week) behind government/military (1,661 attacks per week) and education/research (2,314 attacks per week.) And in the United States, Healthcare ranks second in weekly attacks.

For example, with the growth of AI-driven technology, researchers and other security professionals worry hackers may use tools like ChatGPT to create phishing emails and launch other sophisticated cyberattacks.

One piece of potential good news for those working to protect healthcare institutions from cyberattacks is the recent passage of the bi-partisan PATCH Act, introduced by U.S. Senators Bill Cassidy, M.D. (R-LA) and Tammy Baldwin (D-WI) to provide much-needed security and safety measure for healthcare system’s cyber infrastructure. The PATCH Act effort was successfully included in the December 2022 Omnibus Appropriations bill – and is now law of the land.

An expert in cybersecurity and VP of Cyber Safety Strategy for Claroty, Joshua Corman, weighed in on the rise of cyberattacks in healthcare and the efforts to combat them.

Joshua’s Thoughts

“For me, the passage of the PATCH Act has been at least a nine-year journey trying to argue that connected medical technologies need minimum cyber hygiene, just like cars needed seat belts and safety features. So it’s been building trust with the US Food and Drug Administration, helping inform their pre- and post-market guidance, but not backed by statute. There was a 2015 congressional task force for healthcare industry cybersecurity I served on, and ultimately during the pandemic under record-high ransomware attacks as well, we saw that disruption to healthcare tech from accidents and adversaries can precipitate loss of life. This was overdue and now we have it backed by law.

How can it help hospitals? Hospitals have a shared responsibility, both with how defensible and resilient the technology we procure and deploy is, to begin with, so our supply chain of medical devices and medical technologies, plus how well we secure them. Any hospital regardless of size or funding will now benefit from at least minimum cyber hygiene for the devices we procure and deploy, so we have a fighting chance of keeping them free from accidents and adversaries.

And why now? I think I would’ve preferred this nine years ago, but there has been growing recognition that we were prone, we were prey, and we just lacked predator interest. Over the last three years with record-high attacks on healthcare from ransomware and brazen criminal actors, degraded and delayed care affects patient outcomes and even mortality rates, and these protracted ransom attacks have been documented in part by my team at CISA to introduce delays sufficient to lead to loss of life. Congress has taken notice. The White House has taken notice, and there is finally political will to step up here and preserve the trust of the public in this technology.”

Your experts belong here

Every story in MarketScale Healthcare starts with a company putting its clinicians, service-line leaders, and field engineers on the record. Buyers are already reading this topic. The only question is whose experts they find.

Service-line buyers vet vendors quietly, and your clinicians become the proof they find while doing it.

Get your team featuredSee how it works15 minutes, straight to a calendar.

Follow Healthcare Insights

Get new expert content in your inbox.

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. See how AI describes your company today, and where competitors show up instead.

Free workspace

You just read one Healthcare expert. Your company is full of them.

This article was produced through MarketScale. The same platform turns your clinicians, service-line leaders, and field engineers into the articles, video, and social content Healthcare buyers are searching for. Create a free workspace and see it with your own people. No credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale Studio workspace
One video edit a month, on us
AI writing, editing, and publishing tools
In-platform coaching to learn the system

More Healthcare Insights

Scan.com’s $220M round makes imaging an API contract for plans and employers

Scan.com’s $220M round makes imaging an API contract for plans and employers

Scan.com closed $220 million in equity and debt. It’s expanding its U.S. imaging network plus API-based scheduling and results delivery. For health plans and employers, imaging is starting to look like a platform procurement and integration decision, not a directory problem.

  • 01If imaging access is bought via an API, the real spec becomes integration depth: two-way scheduling plus results routing into the EMR, according to Business Wire.
  • 02Scan.com’s mix of $90M equity and $130M debt earmarked for M&A and working capital points to a fast-changing imaging provider network, which can help access but demands discipline in contracting and integration testing.
  • 03The same week’s funding news for Elucid ($55M) suggests AI imaging vendors will keep pushing toward FDA-cleared workflow insertions, a different buying path than network-layer platforms.

Sep 4, 2026

MD&M West 2026 exhibitors pitch audit-ready, AI-ready device platforms

MD&M West 2026 exhibitors pitch audit-ready, AI-ready device platforms

MD&M West 2026 exhibitor messaging suggests compliance testing and AI-ready compute are becoming early decisions, not afterthoughts. Medical Economics described 2026 as a period shaped by rapid technological change, regulatory scrutiny and ongoing economic uncertainty. Medical Design & Outsourcing’s MD&M West 2026 preview points to exhibitors highlighting test equipment, contract manufacturing and other launch support services.

  • 01If a device roadmap includes AI features, the critical path shifts toward data and software evidence that regulators can audit, which means earlier lock-in of compute platforms and test plans, pulling verification and validation into supplier selection.
  • 02MD&M West exhibitor messaging suggests verification and validation capacity is becoming a procurement problem, with rentals and lab-ready gear positioned as a way to avoid booking delays and re-tests, according to Medical Design & Outsourcing.
  • 03With imaging and other new procedural and device concepts moving fast, manufacturing leaders should expect more frequent line-change decisions and component qualification work, as GE HealthCare's photon-counting CT CE mark reported by MedTech Dive and MDDI's New Technologies coverage illustrate.

Sep 3, 2026

Dr. Dana Rosencranz - Cancer Survivor and Chief Medical Physicist

Dr. Dana Rosencranz - Cancer Survivor and Chief Medical Physicist

Dr. Dana Rosencranz brings 23+ years of experience as chief medical physicist at Texas Oncology and personal insight as a breast cancer survivor, enabling her to guide patient support groups and advocate for accessible cancer care. She emphasizes AI's potential in auto-contouring and treatment planning while stressing the need for proper training, validation, and transparency before implementation.

  • 01Over 23 years at Texas Oncology integrating personal cancer survivor experience with clinical expertise to improve patient empathy and support group leadership
  • 02AI in oncology requires human oversight, validation, and transparency; auto-contouring and auto-planning must be combined with staff training and rigorous protocol testing before deployment
  • 03Texas Oncology prioritizes offering state-of-the-art cancer treatments closer to home, including for rural patients, to reduce travel and ensure consistent, personalized care

Sep 3, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Healthcare and beyond.

Book a 15-minute demo

Or call us. No forms required. We pick up. 214-945-2512